1-9 of 9
Mika Nakamae, M.D.,Ph.D.
Close
Sort by
Journal Articles

HLA Haplo-Identical Peripheral Blood Stem Cell Transplantation Using High-Dose Cyclophosphamide Post-Transplantation For Poor Prognosis Or Refractory Acute Leukemia and Myelodysplastic Syndrome: A Prospective Pilot Study At a Single Center

Hirohisa Nakamae, MD, PhD, Hideo Koh, M.D., Ph.D., Mitsutaka Nishimoto, M.D., Ph.D., Yasuhiro Nakashima, M.D., Ph.D., Satoru Nanno, M.D., Takuro Yoshimura, M.D., Ph.D., Shiro Koh, M.D., Hiroshi Okamura, M.D., Jyoji Nagasaki, M.D., Takahiko Nakane, M.D., Ph.D., Mika Nakamae, M.D., Ph.D., Asao Hirose, M.D., Ph.D., Masayuki Hino, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3404.
https://doi.org/10.1182/blood.V122.21.3404.3404
Published: 2013
Journal Articles

Diagnostic Value Of Serum Level Of Soluble CD14-Subtype In Febrile Neutropenia In Patients With Hematologic Disorders

Hideo Koh, M.D., Ph.D., Hirohisa Nakamae, MD, PhD, Mizuki Aimoto, M.D., Takako Katayama, Asao Hirose, M.D., Ph.D., Mika Nakamae, M.D., Ph.D., Masayuki Hino, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4718.
https://doi.org/10.1182/blood.V122.21.4718.4718
Published: 2013
Journal Articles

Immunoprofile of Patients with Chronic Myeloid Leukemia Treated with Imatinib, Nilotinib or Dasatinib,

Yoshiki Hayashi, M.D., Hirohisa Nakamae, MD, PhD, Takako Katayama, Takahiko Nakane, M.D., Ph.D., Hideo Koh, M.D., Ph.D, Mitsutaka Nishimoto, M.D., Mika Nakamae, M.D., Ph.D, Masahiro Yoshida, M.D., Masato Bingo, M.D., Hiroshi Okamura, M.D., Mizuki Aimoto, M.D., Masahiro Manabe, M.D., Takuro Yoshimura, M.D., Akiko Inaba, M.D., Satoshi Nanno, M.D., Kiyoyuki Hagihara, M.D., Ph.D, Yoshitaka Nakao, M.D., Ph.D, Yoshiki Terada, M.D., Ph.D., Masayuki Hino, M.D., Ph.D.
Journal: Blood
Blood (2011) 118 (21): 3764.
https://doi.org/10.1182/blood.V118.21.3764.3764
Published: 2011
Journal Articles

Risk Factors Affecting Cardiac Left Ventricular Systolic and Diastolic Function and Hypertrophy in the Chronic Phase Post-Allogeneic Hematopietic Cell Transplantation

Mitsutaka Nishimoto, M.D., Hirohisa Nakamae, MD, PhD, Takahiko Nakane, M.D., Ph.D., Hideo Koh, M.D., Ph.D, Yoshiki Hayashi, M.D., Mika Nakamae, M.D., Ph.D, Masahiro Yoshida, M.D., Masato Bingo, M.D., Hiroshi Okamura, M.D., Mizuki Aimoto, M.D., Masahiro Manabe, M.D., Takuro Yoshimura, M.D., Akiko Inaba, M.D., Satoshi Nanno, M.D., Asao Hirose, M.D., Ph.D., Kiyoyuki Hagihara, M.D., Ph.D, Yoshitaka Nakao, M.D., Ph.D, Yoshiki Terada, M.D., Ph.D., Masayuki Hino, M.D., Ph.D.
Journal: Blood
Blood (2011) 118 (21): 2000.
https://doi.org/10.1182/blood.V118.21.2000.2000
Published: 2011
Journal Articles

Outcome After First Relapse In Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

Shinichi Kako, MD, Heiwa Kanamori, MD, Naoki Kobayashi, MD, Akio Shigematsu, MD, Yasuhito Nannya, MD, Mika Nakamae, M.D., Ph.D, Kazuyuki Shigeno, MD, Kazumi Suzukawa, MD, Masahiro Takeuchi, MD, Motohiro Tsuzuki, MD, Kensuke Usuki, MD, Kazuo Hatanaka, MD, Kazuei Ogawa, MD, Kinuko Mitani, MD, Yuichiro Nawa, MD, Yoshihiro Hatta, MD, Ishikazu Mizuno, MD, Yoshinobu Kanda, MD
Journal: Blood
Blood (2011) 118 (21): 3084.
https://doi.org/10.1182/blood.V118.21.3084.3084
Published: 2011
Journal Articles

Factors That Contribute to Long-Term Survival In Patients with Leukemia Not In Remission at Allogeneic Hematopoietic Cell Transplantation

Hideo Koh, M.D, Hirohisa Nakamae, M.D., Ph.D., Takahiko Nakane, M.D., Ph.D., Masahiro Manabe, M.D., Yoshiki Hayashi, M.D., Mitsutaka Nishimoto, M.D., Kaori Umemoto, Mika Nakamae, M.D., Ph.D., Asao Hirose, M.D., Ph.D., Eri Inoue, M.D., Atsushi Inoue, M.D., Masahiro Yoshida, M.D., Masato Bingo, M.D., Hiroshi Okamura, M.D., Ran Aimoto, M.D., Mizuki Aimoto, M.D., Yoshiki Terada, M.D., Ph.D., Ki-Ryang Koh, M.D., Ph.D., Takahisa Yamane, M.D., Ph.D., Masayuki Hino, M.D., Ph.D
Journal: Blood
Blood (2010) 116 (21): 3551.
https://doi.org/10.1182/blood.V116.21.3551.3551
Published: 2010
Journal Articles

Possible Involvement of γδ-T Cells in the Development of Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Ki-Ryang Koh, MD, PhD, Hirohisa Nakamae, M.D., Ph.D., Kensuke Ohta, M.D., Ph.D., Hongzhang Li, M.D., Hideo Koh, M.D., Takahiko Nakane, M.D., Yasunobu Takeoka, M.D., Asao Hirose, M.D., Ph.D., Kiyoyuki Hagihara, M.D., Ph.D., Erina Sakamoto, M.D., Ph.D., Mika Nakamae, M.D., Ph.D., Yoshiki Terada, M.D., Ph.D., Takahisa Yamane, M.D., Ph.D., Masayuki Hino, M.D., Ph.D.
Journal: Blood
Blood (2007) 110 (11): 1971.
https://doi.org/10.1182/blood.V110.11.1971.1971
Published: 2007
Journal Articles

Non-TBI, Non-ATG Containing Fludarabine-Based Regimen for Unrelated Allogeneic Reduced Intensity Transplantation.

Hirohisa Nakamae, MD, PhD, Takahiko Nakane, M.D., Hideo Koh, M.D., Yasunobu Takaoka, M.D.,Ph.D., Erina Sakamoto, M.D.,Ph.D., Hiroshi Kanashima, M.D.,Ph.D., Hiroyoshi Ichihara, M.D., Mika Nakamae, M.D.,Ph.D., Ki-Ryang Koh, M.D.,Ph.D., Takahisa Yamane, M.D.,Ph.D., Masayuki Hino, M.D.,Ph.D.
Journal: Blood
Blood (2006) 108 (11): 5382.
https://doi.org/10.1182/blood.V108.11.5382.5382
Published: 2006
Journal Articles

Decreased Serum Levels of Surfactant Protein D (SP-D) Prior Transplant Is Associated with the Development of Bronchiolitis Obliterans (BO) and Idiopathic Pneumonia Syndrome (IPS) Following Allogeneic Hematopoietic Stem Cell Transplantation.

Takahiko Nakane, MD, Hirohisa Nakamae, M.D.,Ph.D., Hiroshi Kamoi, M.D.,Ph.D., Hideo Koh, M.D., Yasunobu Takeoka, M.D., Erina Sakamoto, M.D.,Ph.D., Hiroshi Kanashima, M.D.,Ph.D., Hiroyoshi Ichihara, M.D., Mika Nakamae, M.D.,Ph.D., Ki-Ryang Koh, M.D.,Ph.D., Takahisa Yamane, M.D.,Ph.D., Masayuki Hino, M.D.,Ph.D.
Journal: Blood
Blood (2006) 108 (11): 2915.
https://doi.org/10.1182/blood.V108.11.2915.2915
Published: 2006